Acumen Pharmaceuticals Inc (NASDAQ:ABOS)
| 4.03 Delayed Data As of Mar 23 |  -0.05 / -1.23%Today’s Change | 3.02 Today|||52-Week Range 10.97 | -25.37% Year-to-Date |
Latest ABOS News | Press Releases
No recent news for Acumen Pharmaceuticals Inc.
Today’s Trading
| Previous close | 4.08 |
| Today’s open | 4.10 |
| Day’s range | 3.97 - 4.20 |
| Volume | 3,237 |
| Average volume (3 months) | 95,853 |
| Market cap | $164.1M |
Data as of 3:59pm ET, 03/23/2023
Growth & Valuation
| Earnings growth (last year) | -1,262.77% |
| Earnings growth (this year) | +79.87% |
| Earnings growth (next 5 years) | +9.66% |
| Revenue growth (last year) | -100.00% |
| P/E ratio | 3.3 |
| Price/Sales | -- |
| Price/Book | 0.72 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | March 27, 2023 |
| EPS forecast (this quarter) | -$0.28 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$100.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
